CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MAGNOSTICS focuses on developing magnetic nanoparticles coated with cancer cell membranes for treating triple-negative breast cancer. This approach combines chemotherapy, gene targeting, and magnetic hyperthermia to enhance treatment efficacy and promote cellular uptake.
Cancer is a leading cause of death and is a major impediment to increasing life expectancy around the globe.
Amongst all breast cancers (BC), triple-negative breast cancers (TNBCs), are of much concern, as chemotherapy is the only option.
However, it is associated with chemoresistance owing to drug efflux.
Moreover, since TNBCs are negative for estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER 2), treatment strategies targeting these receptors do not work.
Combi…
LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA LIN
INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
